Ibn Sina Pharma (S.A.E) (CASE:ISPH) signed an agreement to acquire 75% stake in 3elagi Tech on November 9, 2020. As per the transaction, remaining 25% stake will remain with founders of 3elagi Tech. The founders will stay with the existing management team.